Please check your internet connection and try again.
# Walethmade Bromide
## Overview
Walethmade bromide is a bromide salt that acts as a central nervous system depressant. It is not a widely used medication due to safety concerns and the availability of more effective alternatives.
## Primary Indications
Historically used as a sedative and anticonvulsant, its use is now very limited.
## Adult Dosing
Dosing is highly variable and depends on the historical indication and patient response. It is generally not recommended for routine use. If used for epilepsy, typical starting doses might be in the range of 300-600 mg orally daily, divided into doses. Doses may be increased gradually. *Specific dosing depends heavily on historical protocols and physician judgment and is not standardized for current practice.*
## Pediatric Dosing
Dosing in pediatric patients is not well-established and carries significant risks. If used, it would be at the discretion of a specialist, with extreme caution and careful monitoring.
## Dose Adjustments
Dose adjustments are typically guided by therapeutic response and toxicity. Due to the risk of accumulation, gradual dose increases and decreases are advised.
## Contraindications
* Hypersensitivity to bromide salts.
* Severe renal impairment, as bromide is renally excreted and can accumulate.
* Pregnancy and breastfeeding (potential risks to fetus/infant).
## Adverse Effects
* **Neurological:** Drowsiness, lethargy, confusion, ataxia, memory impairment, psychosis (bromism).
* **Gastrointestinal:** Nausea, vomiting, abdominal pain.
* **Dermatological:** Acneiform rash, bromoderma.
* **Endocrine:** Hypothyroidism, hypercalcemia.
**Bromism** is a chronic toxicity characterized by neurological and psychiatric symptoms, often developing after prolonged use or high doses.
## Key Drug Interactions
* **CNS Depressants (e.g., alcohol, benzodiazepines, opioids, sedatives):** Additive CNS depression, increasing the risk of sedation and respiratory depression.
* **Diuretics (e.g., loop, thiazide):** May increase bromide excretion, potentially leading to lower serum bromide levels. Conversely, impaired renal function combined with diuretics could theoretically worsen accumulation if not managed.
* **Mineralocorticoids:** May decrease bromide excretion.
## Monitoring
* **Serum bromide levels:** Essential for assessing therapeutic range and toxicity, especially with chronic use or impaired renal function. Therapeutic levels are typically in the range of 25-50 mg/dL (2.5-5 mEq/L), with toxicity often occurring above 100 mg/dL (10 mEq/L).
* **Renal function:** Monitor BUN and creatinine, as impaired renal function increases the risk of accumulation.
* **Neurological and psychiatric status:** Assess for signs and symptoms of CNS depression or bromism.
* **Electrolytes:** Including calcium.
## Clinical Pearls
* Walethmade bromide has a long half-life (approximately 12 days), leading to slow accumulation and elimination.
* Toxicity (bromism) can mimic other neurological and psychiatric disorders, making diagnosis challenging.
* Due to significant safety concerns and the availability of safer, more effective alternatives, walethmade bromide is rarely used in modern practice. Its use should be reserved for specific, refractory cases under expert guidance.
* If discontinuation is necessary, gradual tapering is recommended to avoid withdrawal symptoms.
***
*This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider to ensure that the information provided is appropriate for your specific situation and to review the most current prescribing information.*
